Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Featured News from MarketBeat Media 3 Stocks Under $5 With Strong Analyst Upside PotentialReported by Chris Markoch. Publication Date: 2/24/2026. 
At a Glance - Grab Holdings is gaining analyst support as revenue growth and its first full year of profitability highlight long-term opportunity in Southeast Asia’s expanding digital economy.
- Vaxart offers speculative biotech upside with its oral vaccine platform targeting influenza, norovirus, and COVID-19, creating a high-risk, high-reward setup.
- ThredUp is positioned to benefit from the fast-growing resale market, with strong institutional ownership and industry forecasts pointing to sustained secondhand demand.
While many investors are rotating out of speculative penny stocks, others continue to embrace the risk-reward trade-off. Stocks trading under $5 carry meaningful risk: many of these companies are unprofitable, and some generate little or no revenue. Additionally, these are typically small-cap companies. Small-caps have underperformed in recent years, and even though the Russell 2000 is showing some signs of life, that strength hasn't been broadly reflected across the small-cap sector. I Met Elon Musk "Face-to-Face"
During a private gathering of Wall Street elites, I was one of two people selected to speak with Elon personally.
As a result, my research now leads me to believe Elon will announce the SpaceX IPO on this date:
March 26, 2026. Circle it on your calendar.
I'm sharing an "access code" that lets anyone grab a pre-IPO stake before it happens. This is your invitation to the biggest wealth-building event of the decade. Click Here to See how to Get Your "SpaceX Access Code" That could change in 2026 if the economic outlook continues to improve, allowing capital to flow back into speculative names. As always, quality matters. One simple way to screen for higher-quality ideas among low-priced stocks is to look for names with positive analyst sentiment. That's true of the three stocks below. Each lets investors establish a meaningful position with a modest investment while preserving the potential for substantial upside over the next five years. Profitability Milestone Meets Long-Term Emerging Market Growth Emerging market equities are expected to be among the winners in 2026 — a trend that hasn't yet supported Grab Holdings Inc. (NASDAQ: GRAB), which is down roughly 15% this year. Based in Singapore, Grab operates a super app that blends technology, e-commerce and fintech services. Part of the recent pullback reflects Grab's proposed merger with Indonesian rival GoTo. The deal is not final and could face regulatory changes in Indonesia that might limit the company's earnings potential in that market. The company also came in a bit light on the top line in its Q4 2025 earnings report. Some context is important: revenue grew 19% year-over-year, and 2025 marked Grab's first full year of profitability. Analysts are forecasting about 120% earnings growth over the next 12 months. That helps explain why sentiment remains constructive. GRAB has a consensus price target of $6.47, roughly 54% above the current share price. High-Risk Biotech With Platform Potential Biotechnology is a natural hunting ground for penny stock investors because the sector is defined by high risk and potentially high reward. One company to watch is Vaxart Inc. (OTCMKTS: VXRT), the only name on this list that meets the classic penny-stock definition. At the time of writing, VXRT traded just over $0.60 per share. Analyst coverage is light: the single analyst rating issued in the past 12 months is a Buy with a $2 price target. It's common for analysts to skip clinical-stage biotechs. Vaxart's candidates are still in trials, but the upside is straightforward: the company is developing oral vaccines targeting influenza, norovirus and COVID-19. Beyond the convenience of oral delivery and the potential to avoid needle aversion, Vaxart says its platform may elicit a broader immune response that could offer wider protection. Institutional ownership is modest at about 18%, but dollar-volume inflows have outpaced outflows by nearly 10:1, which is notable given the company's stage. Resale Tailwinds Could Turn Today's Losses Into Tomorrow's Gains ThredUp Inc. (NASDAQ: TDUP) is down about 33% in 2026, but a longer view helps. Over the past 12 months TDUP is up more than 66%, suggesting the recent drop may be a normal pullback as investors avoid unprofitable companies. In ThredUp's case, the caveat is "yet." The company operates an online consignment and thrift marketplace that is gaining traction with Gen Z — reflected in revenue, which rose 12.5% year-over-year in the most recent quarter. ThredUp cites a GlobalData 2025 market survey forecasting U.S. secondhand market gross merchandise value will grow at a 9% compound annual growth rate through 2029. Institutions own an impressive 89% of TDUP shares. Dollar-value buying has outpaced selling by about 2:1, and the number of buyers exceeds sellers roughly 3:1. That said, short interest is around 17%, which could add near-term volatility. The consensus price target from six analysts is $12.50, which would represent more than a 190% gain from the current price at the time of this writing.
| 
